Member access

4-Traders Homepage  >  Shares  >  Copenhagen Stock Exchange  >  Novo Nordisk A/S    NOVO.B   DK0060534915

NOVO NORDISK A/S (NOVO.B)

128
Delayed Quote. Delayed BATS Europe - 04/23 11:30:00 am
245.1 DKK   +0.33%
5h ago NOVO NORDISK A/S : Studies from Novo Nordisk Further Understanding of Proin..
8h ago NOVO NORDISK A/S : Share repurchase programme
10h ago Novo Nordisk A/S - Share repurchase programme
SummaryChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Latest news on NOVO NORDISK A/S
5h ago NOVO NORDISK A/S : Studies from Novo Nordisk Further Understanding of Proinsulin
8h ago NOVO NORDISK A/S : Share repurchase programme
10h ago Novo Nordisk A/S - Share repurchase programme
10h ago NOVO NORDISK A/S : Reduction of the share capital
10h ago Novo Nordisk A/S - Reduction of the share capital
1d agoDJEUROPE MARKETS : Drug Stocks Drive European Markets Higher
1d agoDJEUROPE MARKETS : Drug Stocks Drive European Markets Higher
1d agoDJEUROPE MARKETS : Drug Stocks Drive European Markets Higher
2d ago NOVO NORDISK A/S : Three Johns Hopkins Faculty Win Novo Nordisk Awards For Diabe..
4d ago NOVO NORDISK A/S : She stanched the bleeding
4d ago NOVO NORDISK A/S : Three Johns Hopkins Faculty Win Novo Nordisk Awards for Diabe..
5d ago EXCLUSIVE : Biogen prices hemophilia drug on par with older therapies
04/15DJGlaxo Wins U.S. Approval for Diabetes Drug
04/15DJGlaxo Wins U.S. Approval for Diabetes Treatment Albiglutide
04/15 JUPITER EUROPEAN OPPORTUNITIES : Outperforms Benchmark
04/14DJNOVO NORDISK A/S : Seeks to Boost Sales of Insulin in U.S., Mexico
04/14 NOVO NORDISK A/S : Share repurchase programme
04/14 Novo Nordisk A/S - Share repurchase programme
04/10 NOVO NORDISK A/S : UCL and Novo Nordisk partner to take action against urban dia..
04/08 NOVO NORDISK A/S : New model needed in diabetes care
04/07 NOVO NORDISK A/S : Share repurchase programme
04/07 Novo Nordisk A/S - Share repurchase programme
04/02 Sanofi eyes more acquisitions, sees growth in Africa
04/01 NOVO NORDISK A/S : Status regarding Novo Nordisk's holding of its own shares (31..
04/01 NOVO NORDISK A/S : Status regarding Novo Nordisk's holding of its own shares (31..
04/01 Novo Nordisk A/S - Share repurchase programme
03/31 NOVO NORDISK A/S : Reed protects, extends special diabetes program
03/29 Industry experts gather in London to capitalise on the $3.09bn lyophilisation..
03/28 NOVO NORDISK A/S : Reed Protects, Extends Special Diabetes Program
03/28 NOVO NORDISK A/S : Launches 'Cities Changing Diabetes' to Fight Urban Diabetes
03/28 NOVO NORDISK A/S : launches ’Cities Changing Diabetes’ to fight urba..
03/27 Tonghua Dongbao Competitive with Multinational Drug Makers
03/26 NOVO NORDISK A/S : Researchers Submit Patent Application, "Purification of Insul..
03/26 NOVO NORDISK A/S : Patent Issued for Automatic Injection Device with Reset Featu..
03/26 NOVO NORDISK A/S : Reports Outline Physical Chemistry Study Results from Novo No..
03/26 NOVO NORDISK A/S : New Immunoglobulins Study Findings Reported from Novo Nordisk
03/26 NOVO NORDISK A/S : Data on Diabetes Discussed by Researchers at Novo Nordisk
03/26 NOVO NORDISK A/S : Prime Access Tapped to Carry out Novo Nordisk's Diabetes Effo..
03/26 NOVO NORDISK A/S : Investigation Report on China's Insulin Aspart Market to 2018
03/25 NOVO NORDISK A/S : Trading in Novo Nordisk shares by board members, executives a..
03/24 NOVO NORDISK A/S : Share repurchase programme
03/24 Novo Nordisk A/S - Share repurchase programme
03/24 Global Type 2 Diabetes Drug Market (T2D) Forecast & Analysis to 2022 in a New..
03/21 NOVO NORDISK A/S : 2014 long-term, share based incentive programme for Novo Nord..
03/21 NOVO NORDISK A/S : ex-dividend day for annual dividend
03/20 NOVO NORDISK A/S : Resolutions from the Annual General Meeting of Novo Nordisk A..
03/20 NOVO NORDISK A/S : Resolutions from the Annual General Meeting
03/19 NOVO NORDISK A/S : Findings from Novo Nordisk in the Area of Colitis Reported
03/19 NOVO NORDISK A/S : Researchers Submit Patent Application, "Pharmaceutical Formul..
03/19 NOVO NORDISK A/S : Reports from Novo Nordisk Add New Data to Findings in Diabete..
03/19 NOVO NORDISK A/S : Positive results from first phase 3 trial with N8-GP, a long-..
03/19 Novo Nordisk reports positive results from first phase 3 trial with N8-GP, a ..
03/19 NOVO NORDISK A/S : Bitter sweet: Delayed diagnosis causes complications among di..
03/17 NOVO NORDISK A/S : invests 550 million Danish kroner in new purification pilot p..
03/17 NOVO NORDISK A/S : Share repurchase programme
03/17 Novo Nordisk A/S - Share repurchase programme
03/14 NOVO NORDISK A/S : invests 550 million Danish kroner in new purification pilot p..
03/14DJNOVO NORDISK A/S : Novo Nordisk Invests DKK550 Million in New R&D Facility
03/12 NOVO NORDISK A/S : Researchers at Novo Nordisk Target Proinsulin
03/12 NOVO NORDISK A/S : New Findings from Novo Nordisk in the Area of Proinsulin Desc..
03/10 NOVO NORDISK A/S : Share repurchase programme
03/10 Novo Nordisk A/S - Share repurchase programme
03/07DJEUROPE MARKETS : European Stocks Head For Weekly Loss Ahead Of U.S. Data
03/07DJEUROPE MARKETS : European Stocks Head For Weekly Loss Ahead Of U.S. Data
03/05 NOVO NORDISK A/S : Study Results from Novo Nordisk Update Understanding of Weigh..
03/04 NOVO NORDISK A/S : PIMS diabetic clinic upgraded
03/04 NOVO NORDISK A/S : Head of Denmark’s largest company in Pakistan discusses..
03/03 NOVO NORDISK A/S : Share repurchase programme
03/03 Novo Nordisk A/S - Share repurchase programme
03/01 NOVO NORDISK A/S : Pakistan : NOVO NORDISK plans to endow in numerous training a..
03/01 NOVO NORDISK A/S : Diabetes in Pakistan to double by 2035
02/28 NOVO NORDISK A/S : US Specialty Pharmaceutical Market Research Report: 2013: Wor..
02/27 NOVO NORDISK A/S : Election of employee representatives to the Board of Director..
02/27 NOVO NORDISK A/S : Election of employee representatives to the Board of Director..
02/26 NOVO NORDISK A/S : Patent Issued for Skin Retention Device for a Medical Jet Inj..
1  2  3  4  5  6  7Next
Advertisement
Chart
Duration : Period :
Novo Nordisk A/S Technical Analysis Chart | NOVO.B | DK0060534915 | 4-Traders
Income Statement Evolution
Novo Nordisk A_S : Income Statement Evolution
More Financials
Dynamic quotes  
ON
| OFF